Showing results (221-230 of 372) with videos related to
Sort By:
Pageof 38
Cancer Research|February 7, 2007
Distinct genetic signatures among pilocytic astrocytomas relate to their brain region originMukesh K Sharma, David B Mansur, Guido Reifenberger, et al.International Journal of Cancer|March 12, 2014
Assessment and prognostic significance of the epidermal growth factor receptor vIII mutation in glioblastoma patients treated with concurrent and adjuvant temozolomide radiochemotherapyMichael Weller, Kerstin Kaulich, Bettina Hentschel, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2006
Phase II trial of lomustine plus temozolomide chemotherapy in addition to radiotherapy in newly diagnosed glioblastoma: UKT-03Ulrich Herrlinger, Johannes Rieger, Dorothee Koch, et al.Journal of Neuro-Oncology|November 17, 2023
The long non-coding RNA OTX2-AS1 promotes tumor growth and predicts response to BCL-2 inhibition in medulloblastomaNan Qin, Eunice Paisana, Daniel Picard, et al.Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|February 18, 2011
Association of stem cell-related markers and survival in astrocytic gliomasFeng Wan, Christel Herold-Mende, Benito Campos, et al.Neurology|March 17, 2017
Limited role for extended maintenance temozolomide for newly diagnosed glioblastomaDorothee Gramatzki, Philipp Kickingereder, Bettina Hentschel, et al.Annals of Neurology|June 29, 2011
NOA-05 phase 2 trial of procarbazine and lomustine therapy in gliomatosis cerebriMartin Glas, Oliver Bähr, Jörg Felsberg, et al.Nature Communications|November 26, 2014
Loss of PHD3 allows tumours to overcome hypoxic growth inhibition and sustain proliferation through EGFRAnne-Theres Henze, Boyan K Garvalov, Sascha Seidel, et al.Neuro-Oncology|June 29, 2021
The 2021 WHO Classification of Tumors of the Central Nervous System: a summaryDavid N Louis, Arie Perry, Pieter Wesseling, et al.Cell Death Discovery|April 5, 2022
EIF4EBP1 is transcriptionally upregulated by MYCN and associates with poor prognosis in neuroblastomaKai Voeltzke, Katerina Scharov, Cornelius Maximilian Funk, et al.Pageof 38